Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participants.

Setnik B, Sokolowska M, Johnson F, Oldenhof J, Romach M.

Hum Psychopharmacol. 2014 May;29(3):251-65. doi: 10.1002/hup.2394. Epub 2014 Mar 13.

PMID:
24911576
2.

Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2.

Oldenhof J, Hochberg M, Schiff M, Brune K.

Curr Med Res Opin. 2010 Jun;26(6):1497-504. doi: 10.1185/03007995.2010.481249.

PMID:
20429831
3.

Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.

Schiff M, Hochberg MC, Oldenhof J, Brune K.

Curr Med Res Opin. 2009 Oct;25(10):2471-7. doi: 10.1185/03007990903185706.

PMID:
19678751
4.

Systemic responses to hemodilution after transfusion with stored blood and with a hemoglobin-based oxygen carrier.

Torres Filho IP, Spiess BD, Barbee RW, Ward KR, Oldenhof J, Pittman RN.

Anesth Analg. 2005 Apr;100(4):912-20.

PMID:
15781498
5.

SH3 ligands in the dopamine D3 receptor.

Oldenhof J, Ray A, Vickery R, Van Tol HH.

Cell Signal. 2001 Jun;13(6):411-6.

PMID:
11384839
6.

The dopamine D(4) receptor: one decade of research.

Oak JN, Oldenhof J, Van Tol HH.

Eur J Pharmacol. 2000 Sep 29;405(1-3):303-27. Review.

PMID:
11033337
7.

SH3 binding domains in the dopamine D4 receptor.

Oldenhof J, Vickery R, Anafi M, Oak J, Ray A, Schoots O, Pawson T, von Zastrow M, Van Tol HH.

Biochemistry. 1998 Nov 10;37(45):15726-36.

PMID:
9843378

Supplemental Content

Loading ...
Support Center